Where clinical experience meets meaningful scientific dialogue.
The ๐๐๐ ๐๐ข๐๐ฅ๐จ๐ ๐ฎ๐ โ ๐๐๐ซ๐๐๐ก๐ข ๐๐ก๐๐ฉ๐ญ๐๐ซ, hosted at ๐๐๐๐, brought together healthcare professionals for an engaging exchange on Chronic Myeloid Leukemia (CML), with discussions centred on evolving treatment approaches, clinical experience, and considerations in long-term disease management.
From expert perspectives to shared clinical experiences, the session provided a platform for meaningful conversations that support ongoing learning in CML care.
Through ๐๐๐ ๐๐ข๐๐ฅ๐จ๐ ๐ฎ๐, Oncogen Pharma remains committed to fostering scientific exchange and connecting healthcare professionals through knowledge-driven conversations.
An engaging exchange of clinical perspectives focused on strengthening dialogue around ๐๐ก๐ซ๐จ๐ง๐ข๐ ๐๐ฒ๐๐ฅ๐จ๐ข๐ ๐๐๐ฎ๐ค๐๐ฆ๐ข๐ (๐๐๐) and the evolving considerations in its management.
The ๐๐๐ ๐๐ข๐๐ฅ๐จ๐ ๐ฎ๐ ๐๐ฎ๐ฅ๐ญ๐๐ง ๐๐ก๐๐ฉ๐ญ๐๐ซ brought healthcare professionals together for meaningful discussion, knowledge sharing, and the exchange of clinical experiences in CML care.
๐๐ง๐๐จ๐ ๐๐ง ๐๐ก๐๐ซ๐ฆ๐ remains committed to fostering scientific dialogue and supporting continuous learning within the oncology community.
The belief that thyroid cancer is โbasically untreatableโ is a myth.
Many thyroid cancers are highly treatable, particularly when detected early. Advances in diagnosis and treatment continue to shape outcomes for patients.
Gynaecological cancers include cervical, ovarian, uterine, vulvar, and vaginal cancers, with each having distinct clinical characteristics and treatment considerations.
A better understanding of these cancers supports informed conversations around womenโs cancer care.
Nearly 20,000 people in Pakistan are diagnosed with blood cancer every year. Blood cancers include different diseases such as leukaemia, lymphoma, and myeloma, each with distinct characteristics and treatment approaches.
Understanding the differences matters when it comes to timely diagnosis and appropriate care.
A meaningful scientific exchange bringing together healthcare professionals from Jinnah Hospital, Mayo Hospital, and The Childrenโs Hospital, Lahore, to share clinical experiences, treatment perspectives, and evolving insights in Chronic Myeloid Leukemia (CML) management.
The session featured esteemed faculty from Mayo Hospital, including Prof. Dr. Abbas Khokhar (HOD, Oncology Department), Dr. Mariyam Akbar, and Dr. Sundas Rafiq, with Dr. Faryal Shoukat presenting a CML case.
Representing Jinnah Hospital, Dr. Kausar Bano (HOD, Oncology Department), Dr. Fareeha Sheikh, Dr. Zaigham Ismail, and Dr. Sarah Ishaq participated in the scientific exchange, while Dr. Amna Hussain presented her session.
From the Paediatric Oncology/Hematology Department, The Childrenโs Hospital, Dr. Sumera Abdul Karim and Dr. Hira Tahir participated, with Dr. Sana Gull presenting โ๐๐๐๐๐ข๐๐ญ๐ซ๐ข๐ ๐๐๐: ๐๐ฅ๐ข๐ง๐ข๐๐๐ฅ ๐๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ ๐๐ง๐ ๐๐จ๐ง๐ญ๐๐ฆ๐ฉ๐จ๐ซ๐๐ซ๐ฒ ๐๐๐ง๐๐ ๐๐ฆ๐๐ง๐ญ.โ
The session generated strong scientific interest and provided an engaging platform for sharing perspectives across adult and paediatric CML care, with the discussion on Paediatric CML particularly appreciated by participating senior consultants.
At ๐๐ง๐๐จ๐ ๐๐ง ๐๐ก๐๐ซ๐ฆ๐, we remain committed to fostering meaningful scientific dialogue and supporting continued learning in cancer care.
Oncogen Pharma
๐๐๐ ๐๐ข๐๐ฅ๐จ๐ ๐ฎ๐ | ๐๐๐ซ๐๐๐ก๐ข ๐๐ก๐๐ฉ๐ญ๐๐ซ
Where clinical experience meets meaningful scientific dialogue.
The ๐๐๐ ๐๐ข๐๐ฅ๐จ๐ ๐ฎ๐ โ ๐๐๐ซ๐๐๐ก๐ข ๐๐ก๐๐ฉ๐ญ๐๐ซ, hosted at ๐๐๐๐, brought together healthcare professionals for an engaging exchange on Chronic Myeloid Leukemia (CML), with discussions centred on evolving treatment approaches, clinical experience, and considerations in long-term disease management.
From expert perspectives to shared clinical experiences, the session provided a platform for meaningful conversations that support ongoing learning in CML care.
Through ๐๐๐ ๐๐ข๐๐ฅ๐จ๐ ๐ฎ๐, Oncogen Pharma remains committed to fostering scientific exchange and connecting healthcare professionals through knowledge-driven conversations.
๐๐ก๐๐ซ๐ข๐ง๐ ๐ค๐ง๐จ๐ฐ๐ฅ๐๐๐ ๐. ๐๐ฑ๐๐ก๐๐ง๐ ๐ข๐ง๐ ๐๐ฑ๐ฉ๐๐ซ๐ข๐๐ง๐๐. ๐๐๐ฏ๐๐ง๐๐ข๐ง๐ ๐๐๐ ๐๐๐ซ๐.
#CMLDialogue #CML #ChronicMyeloidLeukemia #NIBD #Hematology #Oncology #ScientificExchange #ClinicalDialogue #MedicalEducation #CancerCare #OncogenPharma
1 day ago | [YT] | 0
View 0 replies
Oncogen Pharma
๐๐๐ ๐๐ข๐๐ฅ๐จ๐ ๐ฎ๐ | ๐๐ฎ๐ฅ๐ญ๐๐ง ๐๐ก๐๐ฉ๐ญ๐๐ซ
An engaging exchange of clinical perspectives focused on strengthening dialogue around ๐๐ก๐ซ๐จ๐ง๐ข๐ ๐๐ฒ๐๐ฅ๐จ๐ข๐ ๐๐๐ฎ๐ค๐๐ฆ๐ข๐ (๐๐๐) and the evolving considerations in its management.
The ๐๐๐ ๐๐ข๐๐ฅ๐จ๐ ๐ฎ๐ ๐๐ฎ๐ฅ๐ญ๐๐ง ๐๐ก๐๐ฉ๐ญ๐๐ซ brought healthcare professionals together for meaningful discussion, knowledge sharing, and the exchange of clinical experiences in CML care.
๐๐ง๐๐จ๐ ๐๐ง ๐๐ก๐๐ซ๐ฆ๐ remains committed to fostering scientific dialogue and supporting continuous learning within the oncology community.
๐๐จ๐ง๐ง๐๐๐ญ๐ข๐ง๐ ๐๐ฑ๐ฉ๐๐ซ๐ญ๐ข๐ฌ๐. ๐๐๐ฏ๐๐ง๐๐ข๐ง๐ ๐๐ฅ๐ข๐ง๐ข๐๐๐ฅ ๐๐ข๐๐ฅ๐จ๐ ๐ฎ๐.
#CMLDialogue #CML #ChronicMyeloidLeukemia #Hematology #Oncology #ScientificExchange #ClinicalDialogue #MedicalEducation #CancerCare #OncogenPharma
2 days ago | [YT] | 1
View 0 replies
Oncogen Pharma
๐๐ก๐ฒ๐ซ๐จ๐ข๐ ๐๐๐ง๐๐๐ซ: ๐๐จ๐ซ๐ ๐๐ซ๐๐๐ญ๐๐๐ฅ๐ ๐๐ก๐๐ง ๐๐จ๐ฎ ๐๐ข๐ ๐ก๐ญ ๐๐ก๐ข๐ง๐ค
The belief that thyroid cancer is โbasically untreatableโ is a myth.
Many thyroid cancers are highly treatable, particularly when detected early. Advances in diagnosis and treatment continue to shape outcomes for patients.
#ThyroidCancer #CancerCare #OncologyExcellence #MedicalOncology #OncogenPharma #CancerTreatment
2 days ago | [YT] | 1
View 0 replies
Oncogen Pharma
๐๐ก๐ฒ๐ซ๐จ๐ข๐ ๐๐๐ง๐๐๐ซ: ๐๐จ๐ซ๐ ๐๐จ๐ฆ๐ฆ๐จ๐ง ๐๐ฆ๐จ๐ง๐ ๐๐จ๐ฆ๐๐ง
In Pakistan, thyroid cancer is reported more frequently among women than men.
Understanding patterns in thyroid cancer can help put the disease into context and support informed conversations around thyroid health.
#ThyroidCancer #WomensHealth #ThyroidHealth #CancerCare #OncologyCare #OncogenPharma #MedicalOncology
3 days ago | [YT] | 0
View 0 replies
Oncogen Pharma
๐๐ฒ๐ง๐๐๐๐จ๐ฅ๐จ๐ ๐ข๐๐๐ฅ ๐๐๐ง๐๐๐ซ ๐๐๐ง ๐๐๐๐ฎ๐ซ ๐๐ญ ๐๐ข๐๐๐๐ซ๐๐ง๐ญ ๐๐ ๐๐ฌ
Gynaecological cancers are not limited to one stage of life. Symptoms and risk factors can vary depending on the type of cancer.
Understanding these differences can help support appropriate clinical evaluation and care.
#GynaecologicalCancer #WomensHealth #CancerCare #OncologyExcellence #OncogenPharma #Healthcare
5 days ago | [YT] | 1
View 0 replies
Oncogen Pharma
๐๐ฒ๐ง๐๐๐๐จ๐ฅ๐จ๐ ๐ข๐๐๐ฅ ๐๐๐ง๐๐๐ซ๐ฌ: ๐๐ข๐๐๐๐ซ๐๐ง๐ญ ๐๐ฒ๐ฉ๐๐ฌ, ๐๐ข๐๐๐๐ซ๐๐ง๐ญ ๐๐จ๐ง๐ฌ๐ข๐๐๐ซ๐๐ญ๐ข๐จ๐ง๐ฌ
Gynaecological cancers include cervical, ovarian, uterine, vulvar, and vaginal cancers, with each having distinct clinical characteristics and treatment considerations.
A better understanding of these cancers supports informed conversations around womenโs cancer care.
#GynaecologicalCancer #WomensHealth #CancerCare #OncologyCare #OncogenPharma #TrustedNationalPartnerInCancerCare
6 days ago | [YT] | 0
View 0 replies
Oncogen Pharma
Nearly 20,000 people in Pakistan are diagnosed with blood cancer every year. Blood cancers include different diseases such as leukaemia, lymphoma, and myeloma, each with distinct characteristics and treatment approaches.
Understanding the differences matters when it comes to timely diagnosis and appropriate care.
#BloodCancer #Leukaemia #Lymphoma #Myeloma #OncologyCare #OncogenPharma #TrustedNationalPartnerInCancerCare
1 week ago | [YT] | 1
View 0 replies
Oncogen Pharma
๐๐๐ฒ ๐๐ญ๐ญ๐๐ง๐ญ๐ข๐จ๐ง ๐๐จ ๐๐ง๐ฎ๐ฌ๐ฎ๐๐ฅ ๐๐ก๐๐ง๐ ๐๐ฌ
Symptoms associated with gynaecological cancers may include unusual vaginal bleeding, persistent pelvic pain, ๐ฎ๐ง๐ฎ๐ฌ๐ฎ๐๐ฅ ๐ฏ๐๐ ๐ข๐ง๐๐ฅ ๐๐ข๐ฌ๐๐ก๐๐ซ๐ ๐, ๐ฉ๐๐ซ๐ฌ๐ข๐ฌ๐ญ๐๐ง๐ญ ๐๐ฅ๐จ๐๐ญ๐ข๐ง๐ , ๐จ๐ซ ๐๐ก๐๐ง๐ ๐๐ฌ ๐ข๐ง ๐ฆ๐๐ง๐ฌ๐ญ๐ซ๐ฎ๐๐ฅ ๐ฉ๐๐ญ๐ญ๐๐ซ๐ง๐ฌ.
Persistent or unusual symptoms deserve appropriate medical attention and clinical evaluation.
#GynaecologicalCancer #WomensHealth #CancerSymptoms #CancerCare #PatientCare #OncologyCare #OncogenPharma
1 week ago | [YT] | 0
View 0 replies
Oncogen Pharma
Blood cancer refers to a group of cancers that affect the blood, bone marrow, or lymphatic system, including leukaemia, lymphoma, and myeloma.
Each condition has distinct characteristics and requires an individualized approach to diagnosis and management.
Understanding these differences is an important part of advancing cancer care.
#BloodCancer #Leukaemia #Lymphoma #Myeloma #CancerCare #OncologyCare #OncogenPharma #TrustedNationalPartnerinCancerCare
1 week ago | [YT] | 0
View 0 replies
Oncogen Pharma
๐๐๐ ๐๐ข๐๐ฅ๐จ๐ ๐ฎ๐ | ๐๐๐ก๐จ๐ซ๐ ๐๐ก๐๐ฉ๐ญ๐๐ซ
A meaningful scientific exchange bringing together healthcare professionals from Jinnah Hospital, Mayo Hospital, and The Childrenโs Hospital, Lahore, to share clinical experiences, treatment perspectives, and evolving insights in Chronic Myeloid Leukemia (CML) management.
The session featured esteemed faculty from Mayo Hospital, including Prof. Dr. Abbas Khokhar (HOD, Oncology Department), Dr. Mariyam Akbar, and Dr. Sundas Rafiq, with Dr. Faryal Shoukat presenting a CML case.
Representing Jinnah Hospital, Dr. Kausar Bano (HOD, Oncology Department), Dr. Fareeha Sheikh, Dr. Zaigham Ismail, and Dr. Sarah Ishaq participated in the scientific exchange, while Dr. Amna Hussain presented her session.
From the Paediatric Oncology/Hematology Department, The Childrenโs Hospital, Dr. Sumera Abdul Karim and Dr. Hira Tahir participated, with Dr. Sana Gull presenting โ๐๐๐๐๐ข๐๐ญ๐ซ๐ข๐ ๐๐๐: ๐๐ฅ๐ข๐ง๐ข๐๐๐ฅ ๐๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ ๐๐ง๐ ๐๐จ๐ง๐ญ๐๐ฆ๐ฉ๐จ๐ซ๐๐ซ๐ฒ ๐๐๐ง๐๐ ๐๐ฆ๐๐ง๐ญ.โ
The session generated strong scientific interest and provided an engaging platform for sharing perspectives across adult and paediatric CML care, with the discussion on Paediatric CML particularly appreciated by participating senior consultants.
At ๐๐ง๐๐จ๐ ๐๐ง ๐๐ก๐๐ซ๐ฆ๐, we remain committed to fostering meaningful scientific dialogue and supporting continued learning in cancer care.
#CMLDialogue #CML #ChronicMyeloidLeukemia #Hematology #Oncology #ScientificExchange #MedicalEducation #CancerCare #OncogenPharma #LahoreChapter
1 week ago | [YT] | 1
View 0 replies
Load more